Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10780095
Compositions and methods for treating disorders of circadian and diurnal rhythms using pro
granted patentUS 10780131
Ameliorating nervous systems disorders
granted patentUS 10780133
Method for protecting liver and a liver protecting agent
granted patentUS 10774121
Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease
granted patentUS 10774344
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10774390
Methods and compositions for modulating PrfA mediated virulence gene activation in Listeri
granted patentUS 10774118
Peptides having reduced toxicity that stimulate cholesterol efflux
granted patentUS 10772504
Apparatus, systems and methods for intraoperative imaging
granted patentUS 10772828
Controlled release antimicrobial compositions and methods for the treatment of otic disord
granted patentUS 10772861
Administration of serine protease inhibitors to the stomach
granted patentUS 10772333
Mollusk-killing biopesticide
granted patentUS 10765759
Methods of treating an ocular disease or disorder
granted patentUS 10766908
Calcium L-lactate frameworks as naturally degradable carriers
granted patentUS 10766927
Peptides that stimulate subcutaneous adipogenesis
granted patentUS 10765636
Mesoporous silica nanoparticles with a lipid bilayer coating for cargo delivery
granted patentUS 10758632
NIR-conjugated tumor-specific antibodies and uses thereof
granted patentUS 10760048
In vitro production of medial ganglionic eminence precursor cells
granted patentUS 10758496
Estrogen receptor ligand treatment for neurodegenerative diseases
granted patentUS 10758511
Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase
granted patentUS 10758513
Modulators of mitochondrial protein import
granted patentUS 10752920
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10752882
Compositions and methods for treating retinal diseases
granted patentUS 10752581
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective
granted patentUS 10751281
Auris formulations for treating otic diseases and conditions
granted